DYANAVEL XR 20 FDA approval date

The FDA approved DYANAVEL XR 20 on 4 Nov 2021.

FDA approval date
4 Nov 2021

Drug identity has not yet been verified against registry records

Also recorded as AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2021-11-04DayDYANAVEL XR 20FDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA210526", "applicant_as_listed_by_fda": "TRIS PHARMA INC", "brand_names": ["DYANAVEL XR 10", "DYANAVEL XR 15", "DYANAVEL XR 20", "DYANAVEL XR 5"], "active_ingredients": ["AMPHETAMINE", "AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20211104", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026